May 31, 2019 - Roche's (RHHBY) performance has been strong in the year so far, driven by solid growth of Ocrevus, Perjeta, Tecentriq and Hemlibra.
May 31, 2019 - Novartis' (NVS) investigational, once-daily, fixed dose combination asthma candidate, containing indacaterol acetate and mometasone furoate, meets goals.
May 29, 2019 - BMY vs. NVO: Which Stock Is the Better Value Option?
May 29, 2019 - Celgene's (CELG) Revlimid in combination with a rituximab product gets FDA approval for the treatment of adult patients with previously treated follicular lymphoma or marginal zone lymphoma.
May 28, 2019 - And the analyst really likes one in particular.
May 27, 2019 - Novartis (NVS) obtains FDA approvals for a breast cancer drug and a gene therapy for pediatric patients.
May 27, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it takes? Let's find out.
May 27, 2019 - Roche (RHHBY) gets FDA clearance for the expansion of its leading testing menu.
May 23, 2019 - Novartis (NVS) reports encouraging data on combination asthma drug. The company also highlights its growth plans at its annual meet.
May 22, 2019 - Mallinckrodt (MNK) declines after filing suit against HHS and CMS for the protection of Medicaid patient access to Acthar.